Please use this identifier to cite or link to this item: https://doi.org/10.1080/09540260802397560
DC FieldValue
dc.titlePharmacotherapy for schizophrenic inpatients in East Asia - Changes and challenges
dc.contributor.authorShinfuku, N.
dc.contributor.authorTan, C.-H.
dc.date.accessioned2016-12-13T05:39:58Z
dc.date.available2016-12-13T05:39:58Z
dc.date.issued2008-10
dc.identifier.citationShinfuku, N., Tan, C.-H. (2008-10). Pharmacotherapy for schizophrenic inpatients in East Asia - Changes and challenges. International Review of Psychiatry 20 (5) : 460-468. ScholarBank@NUS Repository. https://doi.org/10.1080/09540260802397560
dc.identifier.issn09540261
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/133079
dc.description.abstractObjectives: (1) to review characteristics of prescription patterns of antipsychotic medication in China, Hong Kong, Japan, Korea, Singapore and Taiwan, (2) to examine the changes of prescriptions brought about by the introduction of second generation psychotropic drugs (SGA) in East Asia, (3) to analyse factors contributing to the characteristic use of antipsychotics, and (4) to suggest ways and means to improve the prescription practice of antipsychotics in East Asia. Methods: Authors of this study collaborated with psychiatrists in East Asia to undertake an international survey reviewing prescription patterns of psychotropic medications in East Asia. The REAP (Research on Asian psychotropic prescription patterns) study reviewed the prescription of a large number of schizophrenic inpatients in China, Hong Kong, Japan, Korea, Singapore and Taiwan in 2001 and 2004 using a unified research protocol and questionnaire. Results: Prescription patterns of antipsychotic drugs differ greatly country by country and have recently experienced rapid changes. Our survey shows second generation antipsychotics are frequently used in East Asia. The introduction of SGA resulted in the combined use of first generation psychotropic drugs (FGA) and SGA in East Asia. These changing prescription patterns have created many challenges for psychiatrists in East Asia. © 2008 Informa Healthcare USA, Inc.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1080/09540260802397560
dc.sourceScopus
dc.typeReview
dc.contributor.departmentPHARMACOLOGY
dc.description.doi10.1080/09540260802397560
dc.description.sourcetitleInternational Review of Psychiatry
dc.description.volume20
dc.description.issue5
dc.description.page460-468
dc.description.codenIRPSE
dc.identifier.isiut000260910100010
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

34
checked on Aug 13, 2019

WEB OF SCIENCETM
Citations

35
checked on Aug 13, 2019

Page view(s)

22
checked on Aug 16, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.